Europe is poised for change with a recent flurry of activity around medical cannabis reform and legislation, and Portugal in particular, plays a key role in this expanding market. CannX Lisbon will bring together some of the most important leaders and experts in cannabinoid medicine from all over the world. This will contribute regionally and globally to improve the growing scientific connection in the field. The conference will be preceded by a full-day medical course, “Introduction to Endocannabinology and Medical Cannabis,” taking place on Tuesday, 11 February. With hundreds of attendees, CannX is the ultimate platform for the exchange of high-level scientific knowledge, professional expertise and valuable networking opportunities. An application will be made to the European Accreditation Council for Continuing Medical Education (EACCME) for CME accreditation of CannX Lisbon. The EACCME is an institution of the European Union of Medical Specialists (UEMS) The main program includes 3 exciting tracks – Science, Business, and Agriculture. Session highlights include: - The Latest in Medical Cannabis Research - Autoimmune Diseases - Mental Health Disorders - Patient Wellbeing – Risk and Side Effect Management - Dependency - New Clinical Research on Various Diseases – Dementia, Autism, Diabetes, Tourette’s Syndrome, Gynecological Diseases, Cardiovascular Conditions - Entering the Pharmaceutical Industry – How to Meet Pharma Standards